Zydus Lifesciences Limited (NSE:ZYDUSLIFE)
India flag India · Delayed Price · Currency is INR
1,111.80
-2.00 (-0.18%)
Jul 24, 2026, 3:30 PM IST

Zydus Lifesciences Financials Overview

Millions INR. Fiscal year is Apr - Mar.

Revenue & Profits

Fiscal YearTTMFY 2026FY 2025FY 2024FY 2023FY 2022
Period EndingMar '26 Mar '26 Mar '25 Mar '24 Mar '23 Mar '22
Revenue
271,484271,484232,415195,474172,374151,099
Revenue Growth
16.81%16.81%18.90%13.40%14.08%4.90%
Gross Profit
196,248196,248167,031131,537107,66794,242
Operating Income
58,24958,24959,60245,39228,52824,741
Net Income
50,40050,40045,25538,59519,60344,873
Earnings Per Share
50.0950.0944.9738.1419.3043.83
EPS Growth
11.37%11.37%17.92%97.61%-55.97%110.32%

Revenue by Segment

Fiscal YearTTMFY 2026FY 2025FY 2024FY 2023FY 2022
Period EndingMar '26 Mar '26 Mar '25 Mar '24 Mar '23 Mar '22
Pharmaceuticals (excl. Medical Technologies)
224,121224,121205,415---
Consumer Products
39,54039,54026,97623,12022,44819,788
Medical Technologies
7,8237,82324---
Total
271,484271,484232,415195,474172,374151,099

Cash & Debt

Fiscal YearCurrentFY 2026FY 2025FY 2024FY 2023FY 2022
Period EndingMar '26 Mar '26 Mar '25 Mar '24 Mar '23 Mar '22
Cash & Investments
49,71149,71156,41613,53011,92439,735
Total Debt
125,146125,14632,1808,21911,95142,210
Net Cash (Debt)
-75,435-75,43524,2365,311-27-2,475
Net Cash Growth
--356.34%---
Net Cash Per Share
-74.97-74.9724.095.25-0.03-2.42

Cash Flow & CapEx

Fiscal YearTTMFY 2026FY 2025FY 2024FY 2023FY 2022
Period EndingMar '26 Mar '26 Mar '25 Mar '24 Mar '23 Mar '22
Operating Cash Flow
21,16621,16667,81131,96326,88821,045
Capital Expenditures
-33,940-33,940-16,937-9,066-10,309-12,026
Free Cash Flow
-12,774-12,77450,87422,89716,5799,019
Free Cash Flow Growth
--122.19%38.11%83.82%-63.03%

Margins

Fiscal YearTTMFY 2026FY 2025FY 2024FY 2023FY 2022
Period EndingMar '26 Mar '26 Mar '25 Mar '24 Mar '23 Mar '22
Gross Margin
72.29%72.29%71.87%67.29%62.46%62.37%
Operating Margin
21.46%21.46%25.64%23.22%16.55%16.37%
Pretax Margin
24.75%24.75%26.18%25.21%15.57%19.09%
Profit Margin
18.57%18.57%19.47%19.74%11.37%29.70%
FCF Margin
-4.71%-4.71%21.89%11.71%9.62%5.97%

Dividends

Fiscal YearCurrentFY 2026FY 2025FY 2024FY 2023FY 2022
Period EndingJul '26 Mar '26 Mar '25 Mar '24 Mar '23 Mar '22
Dividend Per Share
1.0001.00011.0003.0006.0002.500
Dividend Per Share Growth
-90.91%-90.91%266.67%-50.00%140.00%-28.57%
Dividend Yield
0.09%0.11%1.26%0.30%1.25%0.74%

Valuation

Fiscal YearCurrentFY 2026FY 2025FY 2024FY 2023FY 2022
Period EndingJul '26 Mar '26 Mar '25 Mar '24 Mar '23 Mar '22
PE Ratio
22.1417.3919.7126.2625.387.95
Forward PE
26.9220.5419.0128.4621.3916.57
P/FCF Ratio
--17.5344.2730.0139.56
PS Ratio
4.073.233.845.192.892.36